title: Genetic risk and protective factors for the idiopathic inflammatory myopathies.
abstract: The idiopathic inflammatory myopathies, or myositis syndromes, are heterogeneous autoimmune diseases defined by chronic muscle inflammation of unknown cause. They likely develop after the interaction of genetic and environmental risk factors in the absence of protective factors. The known genetic risk and protective factors are common alleles at polymorphic immune response loci and vary depending on phenotype. Furthermore, genetic associations are stronger with phenotypes defined by clinical features and autoantibodies than with myositis patients as a whole. Genetic factors for myositis also vary by age of onset, ethnicity, and environmental exposure group. Of interest, risk genes for one phenotype are often protective for another, possibly explaining the mutual exclusivity of many myositis subgroups. International collaborations using genome-wide association studies are needed to identify additional genes, gene-gene, and gene-environment interactions, all of which have pathogenic, therapeutic, and preventative implications for these increasingly recognized disorders.
authors.affiliation: National Institute of Environmental Health Sciences, National Institutes of Health, Room 1W101, Bethesda, MD 20892, USA. ohanlont@niehs.nih.gov
authors.forename: Terrance P
authors.initials: TP
authors.lastname: O'Hanlon
authors.forename: Frederick W
authors.initials: FW
authors.lastname: Miller
mesh_terms: D001741:Black or African American; D000367:Age Factors; D001323:Autoantibodies / Q000235:genetics*; D004781:Environmental Exposure; D020022:Genetic Predisposition to Disease / Q000208:ethnology / Q000235:genetics; D006680:HLA Antigens / Q000235:genetics*; D006801:Humans; D009220:Myositis / Q000208:ethnology / Q000235:genetics*; D012307:Risk Factors; D044465:White People
chemical_list: D001323:Autoantibodies; D006680:HLA Antigens
references.citation: Rheumatology (Oxford). 2007 Dec;46(12):1786-91
references.pmid: 18003662
references.citation: Hum Immunol. 1999 Mar;60(3):255-8
references.pmid: 10321963
references.citation: J Autoimmun. 2006 Aug;27(1):62-8
references.pmid: 16895750
references.citation: J Rheumatol. 1998 May;25(5):1000-2
references.pmid: 9598907
references.citation: J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1056-60
references.pmid: 18258695
references.citation: Ann Neurol. 1990 Apr;27(4):343-56
references.pmid: 2353792
references.citation: Arthritis Rheum. 2008 Oct;58(10):3247-54
references.pmid: 18821667
references.citation: Arthritis Rheum. 2005 Sep;52(9):2607-15
references.pmid: 16142757
references.citation: J Rheumatol. 2004 Sep;31(9):1847-50
references.pmid: 15338511
references.citation: JAMA. 1993 Oct 20;270(15):1846-9
references.pmid: 8411528
references.citation: Arthritis Rheum. 2007 Nov;56(11):3784-92
references.pmid: 17968926
references.citation: Arthritis Rheum. 2000 Oct;43(10):2368-77
references.pmid: 11037898
references.citation: Ann Rheum Dis. 2009 Oct;68(10):1621-5
references.pmid: 18930994
references.citation: Hum Pathol. 1986 Jul;17(7):704-21
references.pmid: 3459704
references.citation: J Immunol. 1994 Mar 1;152(5):2569-76
references.pmid: 8133064
references.citation: Ann Rheum Dis. 2007 Jul;66(7):970-3
references.pmid: 17405833
references.citation: Curr Opin Rheumatol. 1997 Nov;9(6):520-6
references.pmid: 9375281
references.citation: Medicine (Baltimore). 2006 Mar;85(2):111-127
references.pmid: 16609350
references.citation: Arthritis Rheum. 2006 Nov;54(11):3682-9
references.pmid: 17075819
references.citation: J Invest Dermatol. 2002 Dec;119(6):1394-9
references.pmid: 12485445
references.citation: Arthritis Rheum. 2002 Jul;46(7):1885-93
references.pmid: 12124873
references.citation: Arthritis Rheum. 2006 Nov;54(11):3670-81
references.pmid: 17075818
references.citation: Rheumatology (Oxford). 2007 Sep;46(9):1411-6
references.pmid: 17586554
references.citation: Arthritis Rheum. 1983 Feb;26(2):214-6
references.pmid: 6572047
references.citation: Chin Med Sci J. 2002 Sep;17(3):198
references.pmid: 12901547
references.citation: Mol Med. 2007 Jan-Feb;13(1-2):59-68
references.pmid: 17515957
references.citation: J Autoimmune Dis. 2006 Feb 20;3:2
references.pmid: 16504012
references.citation: Clin Exp Immunol. 1995 Jun;100(3):519-28
references.pmid: 7774065
references.citation: Arthritis Rheum. 2004 Mar;50(3):1013-5
references.pmid: 15022353
references.citation: Arthritis Rheum. 2006 Dec;54(12):3979-87
references.pmid: 17133612
references.citation: Arthritis Rheum. 2008 Oct;58(10):3239-46
references.pmid: 18821675
references.citation: Annu Rev Immunol. 2008;26:29-55
references.pmid: 18303998
references.citation: J Rheumatol. 2004 Sep;31(9):1768-74
references.pmid: 15338498
references.citation: Arthritis Res Ther. 2006;8(1):R13
references.pmid: 16507114
references.citation: Arthritis Rheum. 1998 Apr;41(4):710-9
references.pmid: 9550481
references.citation: Arthritis Rheum. 2008 Dec;58(12):3941-50
references.pmid: 19035492
references.citation: Clin Exp Immunol. 2000 Jul;121(1):47-52
references.pmid: 10886238
references.citation: Medicine (Baltimore). 1991 Nov;70(6):360-74
references.pmid: 1659647
references.citation: Hum Immunol. 1995 Nov;44(3):131-5
references.pmid: 8666549
references.citation: Hum Immunol. 1981 Oct;3(2):181-6
references.pmid: 6948801
references.citation: Arthritis Rheum. 1999 Jun;42(6):1285-90
references.pmid: 10366124
references.citation: Hum Mol Genet. 2008 Oct 15;17(R2):R116-21
references.pmid: 18852199
references.citation: Medicine (Baltimore). 2005 Nov;84(6):338-349
references.pmid: 16267409
references.citation: Arthritis Rheum. 1996 Sep;39(9):1507-18
references.pmid: 8814062